Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases.

<h4>Background</h4>The first European case series are detecting a very high frequency of chemosensitive disorders in COVID-19 patients, ranging between 19.4% and 88%.<h4>Methods</h4>Olfactory and gustatory function was objectively tested in 72 COVID-19 patients treated at University Hospital of Sass... View More